NCT05667935 · NOT YET RECRUITING

Cognitive Impairment Cohort Study of the Elderly Population in SheMountain

This is an observational study, not a treatment trial. Researchers in Shanghai are following 2,000 adults aged 60 and older over two years to learn how cognitive impairment develops and progresses. They are collecting brain scans, blood samples, memory tests, speech recordings, and genetic information to build models that may better predict who develops MCI or Alzheimer's. No phase is assigned because no drug or intervention is being tested.

You may qualify if

  • All genders and all ethnic groups aged 60 and above with permanent residence in Tianma area, SheMountain Town, Songjiang District (suburbs), Shanghai.
  • Agree to collect neuropsychiatric scales, biological samples, imaging and other examination information.
  • Agree to participate in this study and sign the informed consent form. And promise to abide by the research procedures, and cooperate with the implementation of the whole process of research

You're excluded if

  • Suffering from severe mental illness, tumor cachexia, severe liver and kidney dysfunction and other serious physical diseases and unable to cooperate
  • Uncorrectable visual or auditory impairment that hampers the completion of related examination.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2022-12-29

View full record on ClinicalTrials.gov

All APOE4 clinical trials